Sufentanil Citrate

   
Google
 
Web NewDrugInformation.com

Sufentanil Citrate


Drug - Sufentanil Citrate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sufentanil Citrate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.05MG BASE/ML
The potency of the active ingredient(s), Sufentanil Citrate. May repeat for multiple part products.

Applicant - STERIS
The firm name holding legal responsibility for Sufentanil Citrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074406
The FDA assigned number to Sufentanil Citrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sufentanil Citrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 15, 1995
The date Sufentanil Citrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sufentanil Citrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Sufentanil Citrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Steris Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Sufentanil Citrate.

Sufentanil Citrate